BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11752812)

  • 1. Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?
    Kägi MK
    Dermatology; 2001; 203(4):280-3. PubMed ID: 11752812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leukotriene receptor antagonists--possible therapeutic option in the treatment of atopic dermatitis ].
    Czarnecka-Operacz M; Jenerowicz D
    Pol Merkur Lekarski; 2003 Jan; 14(79):86-8. PubMed ID: 12712839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
    Angelova-Fischer I; Tsankov N
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis.
    Broshtilova V; Gantcheva M
    Dermatol Ther; 2010; 23(1):90-3. PubMed ID: 20136913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast in allergic diseases beyond asthma.
    Leonardi S; Marchese G; Marseglia GL; La Rosa M
    Allergy Asthma Proc; 2007; 28(3):287-91. PubMed ID: 17619556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
    Yanase DJ; David-Bajar K
    J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leukotriene antagonist. All around talent in asthma and allergies].
    MMW Fortschr Med; 2002 Nov; 144(47):64. PubMed ID: 12532531
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all.
    Chin WK
    J Clin Pharm Ther; 2018 Feb; 43(1):159-162. PubMed ID: 29114905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast can reduce the severity and extent of atopic dermatitis.
    Holme H; Winckworth LC
    J Paediatr Child Health; 2013 May; 49(5):412-5. PubMed ID: 23647765
    [No Abstract]   [Full Text] [Related]  

  • 10. [A leukotriene antagonist (montelukast) in the treatment of atopic dermatitis in pediatric patients].
    Concha del Río LE; Arroyave CM
    Rev Alerg Mex; 2003; 50(5):187-91. PubMed ID: 14631590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast in general pediatric practices.
    Ngamphaiboon J
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene receptor antagonists are ineffective for severe atopic dermatitis.
    Silverberg NB; Paller AS
    J Am Acad Dermatol; 2004 Mar; 50(3):485-6. PubMed ID: 14988703
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and tolerability of montelukast as a therapeutic agent for severe atopic dermatitis in adults.
    Nettis E; Pannofino A; Fanelli M; Ferrannini A; Tursi A
    Acta Derm Venereol; 2002; 82(4):297-8. PubMed ID: 12361137
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukotriene receptor antagonists in chronic urticaria.
    Asero R; Tedeschi A; Lorini M
    Allergy; 2001 May; 56(5):456-7. PubMed ID: 11350316
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway.
    Yanes DA; Mosser-Goldfarb JL
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S71-S75. PubMed ID: 29248523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-resistant atopic dermatitis.
    Wergowske GL
    J Am Geriatr Soc; 2001 Jul; 49(7):1008. PubMed ID: 11527503
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe erythrodermic atopic dermatitis treated with montelukast.
    Broshtilova V; Antonov D; Bardarov E; Tsankov N
    Skinmed; 2003; 2(2):134-6. PubMed ID: 14673317
    [No Abstract]   [Full Text] [Related]  

  • 18. A role for leukotriene antagonists in atopic dermatitis?
    Chari S; Clark-Loeser L; Shupack J; Washenik K
    Am J Clin Dermatol; 2001; 2(1):1-6. PubMed ID: 11702615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults.
    Capella GL; Grigerio E; Altomare G
    Eur J Dermatol; 2001; 11(3):209-13. PubMed ID: 11358726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of montelukast in the treatment of atopic dermatitis.
    Rahman ML; Choudhury AM; Islam MM
    Mymensingh Med J; 2006 Jan; 15(1):85-8. PubMed ID: 16467770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.